|
|
Volumn 4, Issue 1, 2007, Pages 95-104
|
|
From human genetic variations to prediction of risks and responses to drugs and the environment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACENOCOUMAROL;
ANTICOAGULANT AGENT;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
ANTINEOPLASTIC AGENT;
ANTIRETROVIRUS AGENT;
ANTIVITAMIN K;
APOLIPOPROTEIN A1;
APOLIPOPROTEIN A4;
APOLIPOPROTEIN A5;
APOLIPOPROTEIN C3;
APOLIPOPROTEIN E;
CYCLOSPORIN;
CYTOCHROME P450 2D6;
CYTOCHROME P450 3A;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FEXOFENADINE;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MESSENGER RNA;
MULTIDRUG RESISTANCE PROTEIN 1;
NEUROLEPTIC AGENT;
PROTEINASE INHIBITOR;
PSYCHOTROPIC AGENT;
TACROLIMUS;
ATHEROSCLEROSIS;
AUTOPSY;
BLEEDING;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CELL ORGANELLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE COURSE;
DNA METHYLATION;
DNA MICROARRAY;
DRUG BLOOD LEVEL;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG OVERDOSE;
DRUG RESEARCH;
DRUG RESPONSE;
DYSLIPIDEMIA;
ENVIRONMENTAL FACTOR;
FORENSIC MEDICINE;
FUNCTIONAL GENOMICS;
GENE CLUSTER;
GENE EXPRESSION PROFILING;
GENE INTERACTION;
GENE MUTATION;
GENETIC ASSOCIATION;
GENETIC DATABASE;
GENETIC RISK;
GENETIC SCREENING;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
GENOME ANALYSIS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HISTOPATHOLOGY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTENSION;
IATROGENIC DISEASE;
INSULIN RESISTANCE;
ISCHEMIC HEART DISEASE;
KIDNEY DISEASE;
KIDNEY GRAFT REJECTION;
LIPODYSTROPHY;
MEDICAL EDUCATION;
METABOLIC DISORDER;
METABOLIC SYNDROME X;
METABOLOMICS;
MICROARRAY ANALYSIS;
MONOCYTE;
MUTATIONAL ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NUTRIGENOMICS;
OBESITY;
OSTEOPENIA;
PHARMACOGENETICS;
PHARMACOGENOMICS;
PRACTICE GUIDELINE;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTATE CANCER;
PROSTATECTOMY;
PROTEIN ANALYSIS;
PROTEOMICS;
PROTON NUCLEAR MAGNETIC RESONANCE;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RHEUMATIC DISEASE;
RISK ASSESSMENT;
RISK FACTOR;
RNA ANALYSIS;
SCHIZOPHRENIA;
SIDE EFFECT;
SINGLE NUCLEOTIDE POLYMORPHISM;
THROMBOSIS;
TRANSCRIPTOMICS;
UNSPECIFIED SIDE EFFECT;
VASCULAR ENDOTHELIUM;
WEIGHT GAIN;
WEIGHT REDUCTION;
|
|
EID: 33847071220
PISSN: 17410541
EISSN: 1744828X
Source Type: Journal
DOI: 10.2217/17410541.4.1.95 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (1)
|
